James Flory

3.4k total citations · 2 hit papers
83 papers, 2.1k citations indexed

About

James Flory is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Economics and Econometrics. According to data from OpenAlex, James Flory has authored 83 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Endocrinology, Diabetes and Metabolism, 22 papers in Molecular Biology and 14 papers in Economics and Econometrics. Recurrent topics in James Flory's work include Diabetes Treatment and Management (30 papers), Metabolism, Diabetes, and Cancer (20 papers) and Diabetes Management and Research (17 papers). James Flory is often cited by papers focused on Diabetes Treatment and Management (30 papers), Metabolism, Diabetes, and Cancer (20 papers) and Diabetes Management and Research (17 papers). James Flory collaborates with scholars based in United States, United Kingdom and Canada. James Flory's co-authors include Ezekiel J. Emanuel, Kasia J. Lipska, Sean Hennessy, Charles E. Leonard, Dylan S. Small, Alvin I. Mushlin, Ashkan Ertefaie, Christopher G. Rowan, Warren B. Bilker and Colleen Brensinger and has published in prestigious journals such as JAMA, Circulation and Journal of Clinical Oncology.

In The Last Decade

James Flory

78 papers receiving 2.1k citations

Hit Papers

Interventions to Improve Research Participants' Understan... 2004 2026 2011 2018 2004 2019 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Interventions to Improve Research Participants' Understanding in Informed Consent for Research
    2004 739 citations James Flory et al. profile →
  2. Metformin in 2019
    2019 320 citations James Flory et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James Flory United States 21 709 598 432 369 256 83 2.1k
Leonard Feldman United States 18 511 0.7× 587 1.0× 728 1.7× 386 1.0× 298 1.2× 64 2.4k
Rachael K. Ross United States 27 556 0.8× 470 0.8× 502 1.2× 360 1.0× 398 1.6× 102 3.3k
Anjali D. Deshpande United States 22 341 0.5× 382 0.6× 633 1.5× 333 0.9× 315 1.2× 37 3.3k
Judith M. E. Walsh United States 23 416 0.6× 451 0.8× 546 1.3× 182 0.5× 264 1.0× 71 3.0k
Jessica Chubak United States 35 468 0.7× 345 0.6× 252 0.6× 358 1.0× 527 2.1× 166 4.1k
Julie C. Will United States 29 972 1.4× 602 1.0× 542 1.3× 315 0.9× 109 0.4× 74 2.9k
Sandhya Pruthi United States 32 526 0.7× 405 0.7× 409 0.9× 323 0.9× 394 1.5× 120 3.6k
Jeffrey A. Henderson United States 21 381 0.5× 483 0.8× 517 1.2× 114 0.3× 278 1.1× 51 2.0k
Jennifer Hirst United Kingdom 19 358 0.5× 432 0.7× 683 1.6× 495 1.3× 394 1.5× 45 4.0k
Ruy López‐Ridaura Mexico 26 532 0.8× 274 0.5× 457 1.1× 127 0.3× 175 0.7× 110 2.3k

Countries citing papers authored by James Flory

Since Specialization
Citations

This map shows the geographic impact of James Flory's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Flory with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Flory more than expected).

Fields of papers citing papers by James Flory

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Flory. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Flory. The network helps show where James Flory may publish in the future.

Co-authorship network of co-authors of James Flory

This figure shows the co-authorship network connecting the top 25 collaborators of James Flory. A scholar is included among the top collaborators of James Flory based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Flory. James Flory is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Atkinson, Thomas M., Kathleen Lynch, Login S. George, et al.. (2025). Using GPT-4o to interpret patient-reported outcomes without training. JNCI Journal of the National Cancer Institute. 117(4). 809–811.
2.
3.
4.
Liu, Dazhi, et al.. (2023). Sodium-glucose cotransporter-2 inhibitors for hypergycemia in phosphoinositide 3-kinase pathway inhibition. Breast Cancer Research and Treatment. 203(1). 85–93. 5 indexed citations
5.
Flory, James, Jessica S. Ancker, Scott Y. H. Kim, Gilad J. Kuperman, & Andrew J. Vickers. (2023). Decision architecture randomisation: extremely efficient clinical trials that preserve clinician and patient choice?. BMJ evidence-based medicine. 29(2). 71–74.
6.
Dawwas, Ghadeer K., James Flory, Sean Hennessy, Charles E. Leonard, & James D. Lewis. (2022). Comparative Safety of Sodium–Glucose Cotransporter 2 Inhibitors Versus Dipeptidyl Peptidase 4 Inhibitors and Sulfonylureas on the Risk of Diabetic Ketoacidosis. Diabetes Care. 45(4). 919–927. 14 indexed citations
7.
Flory, James, et al.. (2022). Prescriber Uncertainty as Opportunity to Improve Care of Type 2 Diabetes with Chronic Kidney Disease: Mixed Methods Study. Journal of General Internal Medicine. 38(6). 1476–1483. 5 indexed citations
8.
Min, Jea Young, Samprit Banerjee, Fei Wang, et al.. (2022). Association between antidiabetic drug use and the risk of COVID ‐19 hospitalization in the INSIGHT Clinical Research Network in New York City. Diabetes Obesity and Metabolism. 24(7). 1402–1405. 6 indexed citations
9.
Ye, Ting, Ashkan Ertefaie, James Flory, Sean Hennessy, & Dylan S. Small. (2022). Instrumented Difference-in-Differences. Biometrics. 79(2). 569–581. 7 indexed citations
10.
Min, Jea Young, et al.. (2021). Safety and effectiveness of metformin in patients with reduced renal function: A systematic review. Diabetes Obesity and Metabolism. 23(9). 2035–2047. 15 indexed citations
11.
Flory, James, et al.. (2021). Compared to commercially insured patients, Medicare advantage patients adopt newer diabetes drugs more slowly and adhere to them less. Endocrinology Diabetes & Metabolism. 4(3). e00245–e00245. 5 indexed citations
12.
Dawwas, Ghadeer K., Sean Hennessy, Colleen Brensinger, et al.. (2021). Comparative Safety of Dipeptidyl Peptidase‐4 Inhibitors and Sudden Cardiac Arrest and Ventricular Arrhythmia: Population‐Based Cohort Studies. Clinical Pharmacology & Therapeutics. 111(1). 227–242. 2 indexed citations
13.
Huang, Alex Y., et al.. (2021). Rates of Metformin Use in Stage 3b Chronic Kidney Disease Rose After FDA Label Change. Journal of General Internal Medicine. 36(10). 3261–3263. 3 indexed citations
14.
Dawwas, Ghadeer K., Charles E. Leonard, Scott Martin Vouri, et al.. (2020). Twelve‐year trends in pharmacologic treatment of type 2 diabetes among patients with heart failure in the United States. Diabetes Obesity and Metabolism. 22(4). 705–710. 3 indexed citations
15.
Dhopeshwarkar, Neil, Colleen Brensinger, Warren B. Bilker, et al.. (2020). Risk of sudden cardiac arrest and ventricular arrhythmia with sulfonylureas: An experience with conceptual replication in two independent populations. Scientific Reports. 10(1). 10070–10070. 8 indexed citations
16.
Flory, James, et al.. (2019). Reports of Lactic Acidosis Attributed to Metformin, 2015–2018. Diabetes Care. 43(1). 244–246. 20 indexed citations
17.
18.
Ertefaie, Ashkan, Dylan S. Small, James Flory, & Sean Hennessy. (2016). Selection Bias When Using Instrumental Variable Methods to Compare Two Treatments But More Than Two Treatments Are Available. The International Journal of Biostatistics. 12(1). 219–232. 16 indexed citations
19.
Flory, James, et al.. (2016). Proposals to Conduct Randomized Controlled Trials Without Informed Consent: a Narrative Review. Journal of General Internal Medicine. 31(12). 1511–1518. 22 indexed citations
20.
Flory, James, Marshall M. Joffe, Neil O. Fishman, Paul H. Edelstein, & Joshua P. Metlay. (2008). Socioeconomic risk factors for bacteraemic pneumococcal pneumonia in adults. Epidemiology and Infection. 137(5). 717–726. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leonard Feldman Breakdown of academic impact, for papers by Rachael K. Ross Breakdown of academic impact, for papers by Anjali D. Deshpande Breakdown of academic impact, for papers by Judith M. E. Walsh Breakdown of academic impact, for papers by Jessica Chubak Breakdown of academic impact, for papers by Julie C. Will Breakdown of academic impact, for papers by Sandhya Pruthi Breakdown of academic impact, for papers by Jeffrey A. Henderson Breakdown of academic impact, for papers by Jennifer Hirst Breakdown of academic impact, for papers by Ruy López‐Ridaura
Rankless by CCL
2026